Blue Square Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Blue Square Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-347	Closed	-$201K	–	73
2025 Q4	$201K	Buy	+347	New	+$196K	0.09%	69
2024 Q4	–	Sell	-347	Closed	-$215K	–	74
2024 Q3	$215K	Buy	+347	New	+$205K	0.12%	69
2024 Q2	–	Sell	-347	Closed	-$202K	–	79
2024 Q1	$202K	Buy	+347	New	+$195K	0.13%	75
2023 Q2	–	Sell	-347	Closed	-$200K	–	85
2023 Q1	$200K	Buy	+347	New	+$196K	0.13%	77
2022 Q2	–	Sell	-347	Closed	-$205K	–	75
2022 Q1	$205K	Hold	347	–	–	0.17%	69
2021 Q4	$232K	Buy	+347	New	+$217K	0.14%	73
2020 Q3	–	Sell	-347	Closed	-$126K	–	171
2020 Q2	$126K	Buy	+347	New	+$116K	0.09%	85

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Square Asset Management's TMO Position: Q1 2026 in Review

Blue Square Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 347 shares — an estimated $201K sold.

Blue Square Asset Management first reported a position in TMO in Q2 2020 and held it in 7 quarters. The position peaked at $232K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Blue Square Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Blue Square Asset Management sold 347 Thermo Fisher Scientific shares in Q1 2026, an estimated $201K.
Blue Square Asset Management first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 7 quarters.
Blue Square Asset Management's Thermo Fisher Scientific position peaked at $232K in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Blue Square Asset Management's 13F filing for Q1 2026, filed 15 Apr 2026.